BioHealthWays prevents vision loss by delivering biologics in the eye. Our implant drastically reduces injections and improves compliance & convenience. The target market is $7B+, with 12M Americans having retinal neovascular conditions.
03272017_BioHealthWays Executive Summary_v2

No Comments Yet.

Leave a Reply

You must be logged in to post a comment.